−400KRW
−7.40 BKRW
94.08 BKRW
8.96 M
About DUKSAN TECHOPIA
Sector
Industry
CEO
Soo-Wan Lee
Website
Headquarters
Cheonan
Employees (FY)
323
Founded
2006
ISIN
KR7317330009
FIGI
BBG00PKGR3P3
Duksan Technopia Co., Ltd. specializes in fine chemical synthesis in the field of semiconductor/electronic materials and display materials. It develops and manufactures materials for OLED displays, organic phosphors, and organic phosphorous materials; ultra-high purity sources for ALD/CVD precursors; and optical fibers used as thin film deposition compounds for semiconductor fabrication. The company was founded on March 16, 2006 and is headquartered in Cheonan, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 317330 is 38850.00 KRW — it has increased by 1.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DUKSAN TECHOPIA stocks are traded under the ticker 317330.
DUKSAN TECHOPIA revenue for the last quarter amounts to 29.50 B KRW despite the estimated figure of 30.36 B KRW. In the next quarter revenue is expected to reach 27.32 B KRW.
Yes, you can track DUKSAN TECHOPIA financials in yearly and quarterly reports right on TradingView.
Like other stocks, 317330 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DUKSAN TECHOPIA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 323.00 employees. See our rating of the largest employees — is DUKSAN TECHOPIA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DUKSAN TECHOPIA EBITDA is 11.19 B KRW, and current EBITDA margin is 11.89%. See more stats in DUKSAN TECHOPIA financial statements.